Should Rituximab Be Used to Prevent Relapse in Patients with ANCA-Associated Vasculitis?

Documenti analoghi

• Is there a role for TNFα blockade in ANCA-associated vasculitis and glomerulonephritis?
  di: McAdoo, Stephen P, et al.
  Pubblicazione: (2017)
• Rituximab for the Treatment of Relapses in ANCA-associated Vasculitis
  di: Miloslavsky, EM, et al.
  Pubblicazione: (2014)
• Treatment of Relapses in ANCA-Associated Vasculitis
  di: McClure, Mark, et al.
  Pubblicazione: (2019)
• Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis
  di: Smith, Rona M, et al.
  Pubblicazione: (2020)
• PR3-ANCAs predict relapses in ANCA-associated vasculitis patients after rituximab
  di: van Dam, Laura S, et al.
  Pubblicazione: (2020)